We are live on ! Find out more
PRAH

PRA Health Sciences, Inc.
PRAH

Delisted

PRAH was delisted on the 30th of June, 2021.

1 hedge funds and large institutions have $1.93M invested in PRA Health Sciences, Inc. in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 313 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 3171 (-316)

100% less capital invested

Capital invested by funds: $9.92B → $1.93M (-$9.92B)

100% less funds holding in top 10

Funds holding in top 10: 200 (-20)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 313

Holders
1
Holders Change
-316
Holders Change %
-99.68%
% of All Funds
0.02%
Holding in Top 10
Holding in Top 10 Change
-20
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
313
Calls
Puts
Net Calls
Net Calls Change

PRAH Hedge Fund Activity: Q3 2021 in Review

1 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q3 2021, worth a combined $1.93M — down 100% from $9.92B a quarter earlier.

Sellers outnumbered buyers: 313 funds closed out of PRAH and 0 opened new positions — a net loss of 313 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $720M sold.

  • 1 institutional investor held PRA Health Sciences, Inc. (PRAH) as of Q3 2021, down from 317 in Q2 2021.
  • Funds reported $1.93M of PRA Health Sciences, Inc. stock for Q3 2021, down 100% quarter-over-quarter.
  • 0 funds opened new PRA Health Sciences, Inc. positions in Q3 2021 and 313 closed out, a net change of -313 holders.
  • The largest PRA Health Sciences, Inc. seller in Q3 2021 was BlackRock, an estimated $720M sold.

Based on aggregated 13F filings for Q3 2021.